ArticleArthritis research & therapy2025

Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: a nationwide population-based cohort study.

Wei-Sheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.